Jim Cramer fields questions about stocks during his "Lightning Round" segment of Mad Money. I do not have a TV platform but some subscribers to Real Money do send me emails about stocks they are interested in. One subscriber asked about Halozyme Therapeutics (HALO) , a biotechnology company focused on novel biological and drug delivery approaches.
More from Investing
The crypto market looks like it may be headed for hard times.
Let's take a closer look at the Dow Jones industrial average exchange-traded fund.
NFLX may be able to maintain its prime position, but its crown appears not as safe as it once was.
Here are a few ultra-high yield energy master limited partnerships that offer exceptionally high distribution yields with a wide margin of safety.